SCHEMBL4439054

SCHEMBL4439054

O=S(=O)(O)c1nn[nH]c1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ALDH1A1 P00352 5/20 0.36
▸ HPGD P15428 4/20 0.36
▸ KDM4E B2RXH2 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ GAA P10253 2/20 0.35
▸ PLA2G10 O15496 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ RPS6KA3 P51812 3/20 0.33
▸ RCE1 Q9Y256 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ AKR1B1 P15121 1/20 0.33
▸ SERPINE1 P05121 1/20 0.33
▸ LRRK2 Q5S007 2/20 0.32
▸ MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9173123 0.77 GAA (0.39) SMN1; SMN2TSHRALDH1A1HPGDKDM4E
SCHEMBL15301810 0.71 PTGS2 (0.48) PTGS1PTGS2
SCHEMBL8434630 0.71 RPS6KA3 (0.42) SMN1; SMN2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL20028652 0.70 KDM4E (0.46) SMN1; SMN2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL453506 0.69 KDM4E (0.48) SMN1; SMN2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL27873777 0.68 IKBKB (0.46) SMN1; SMN2TSHRALDH1A1HPGDKDM4E
SCHEMBL11810834 0.68 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1HPGDKDM4EGAA
SCHEMBL3683213 0.67 DYRK1B (0.39) SMN1; SMN2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL18039136 0.67 MAPK1 (0.52) SMN1; SMN2ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL541469 0.67 KDM4E (0.38) SMN1; SMN2ALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104916350-B Method for repairing and regenerating transparent conductive film, and transparent conductive laminate 长濑化成株式会社 2020-08-18 — — CN disclosed
US-9944812-B2 Composition for ink and transparent electrode NAGASE CHEMTEX CORPORATION (JP) 2018-04-17 — — US disclosed
CN-106575053-A Transparent conductor, liquid crystal display device and method for producing transparent conductor 长濑化成株式会社 2017-04-19 — — CN disclosed
US-20160196892-A1 CONDUCTIVE RESIN COMPOSITION AND TRANSPARENT CONDUCTIVE LAMINATED BODY NAGASE CHEMTEX CORPORATION (JP) 2016-07-07 — — US disclosed
CN-103237852-B Heat curing-type electroconductibility coating composition, blooming and protective membrane NAGASE CHEMTEX CORP. (JP) 2016-04-06 — — CN disclosed
CN-102559043-B conductive coating composition and laminate NAGASE CHEMTEX CORP. (JP) 2016-03-16 — — CN disclosed
CN-104916350-A Repairing and regeneration method for transparent conductive film and transparent conductive laminating body NAGASE CHEMTEX CORP 2015-09-16 — — CN disclosed
US-20150225589-A1 COMPOSITION FOR INK AND TRANSPARENT ELECTRODE NAGASE CHEMTEX CORPORATION (JP) 2015-08-13 — — US disclosed
CN-104830157-A Composition for ink and transparent electrode NAGASE CHEMTEX CORP 2015-08-12 — — CN disclosed
CN-104629267-A Conductive resin composition and transparent electrically-conductive lamination body NAGASE CHEMTEX CORP 2015-05-20 — — CN disclosed
EP-2671929-A1 INFRARED-REFLECTING SUBSTRATE Nagase ChemteX Corporation (JP) 2013-12-11 — — EP disclosed
US-20130308180-A1 INFRARED REFLECTIVE SUBSTRATE NAGASE CHEMTEX CORPORATION (JP) 2013-11-21 — — US disclosed
CN-103328591-A Infrared-reflecting substrate NAGASE CHEMTEX CORP 2013-09-25 — — CN disclosed
CN-103237852-A Composition for heat-curable conductive coatings, optical film and protective film NAGASE CHEMTEX CORP 2013-08-07 — — CN disclosed
CN-102559043-A Conductive coating composition and laminate NAGASE CHEMTEX CORP 2012-07-11 — — CN disclosed
EP-2121663-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF RIZATRIPTAN Aurobindo Pharma Limited (IN) 2009-11-25 — — EP disclosed
WO-2008075163-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF RIZATRIPTAN AUROBINDO PHARMA LIMITED (IN) 2008-06-26 — — WO disclosed
CN-1989140-A Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation VASOPHARM BIOTECH GMBH (DE) 2007-06-27 — — CN disclosed
Send feedback